The Evolving Role Of Corporate Development In Banking

By Stuart Robertson – KPMG Fewer deals + more strategic projects = greater fulfilment Introduction: The rising and pervasive influence of regulation In the aftermath of the financial crisis, banks’ attention has shifted somewhat from growth to embrace a wider range of activities, from strategic planning to improved operational efficiency.This reflects a growing focus on improving margins, profitability and … Read more

Global Capital Confidence Barometer – Innovation, Complexity And Disruption Define The New M&A Market

By Pip McCrostie – Ernst & Young Our 12th Global Capital Confidence Barometer finds the global M&A market maintaining the positive momentum that developed during 2014. For the first time in five years, more than half our respondents are planning acquisitions in the next 12 months, as deal pipelines continue to expand. Executives express increasing optimism in the … Read more

Emerging Markets Review: Rights Issues And Creeping Acquisitions In India

Emerging Markets Review: Rights Issues And Creeping Acquisitions In India

by Elsevier Ltd.
We analyze the extent to which promoters of firms listed on the Bombay Stock Exchange are using rights issues to circumvent regulatory provisions related to creeping acquisitions. We find that promoters use rights issues that do not have specific objectives for purposes of realizing an increase in their shareholdings. We find that a rights issue often follows a year in which the promoter has realized a loss of shareholdings. […] Read more

Emerging Markets Review: Rights Issues And Creeping Acquisitions In India

By Gaurav Jetley, Shamim S. Mondal Abstract We analyze the extent to which promoters of firms listed on the Bombay Stock Exchange are using rights issues to circumvent regulatory provisions related to creeping acquisitions. We find that promoters use rights issues that do not have specific objectives for purposes of realizing an increase in their shareholdings. We find that a rights issue … Read more

‘Protectionism’ In M&A: A Mixed Picture

Figure 2 Some practical considerations

by Allen & Overy
When a national ‘champion’ is at stake, lively political and media debate often follows, sometimes even where the sector involved is not particularly ‘sensitive’. This is unsurprising in markets facing slow economic growth and, more recently, there has been an interesting interplay between expanding sanctions regimes and policy in this area. […] Read more

Chemicals M&A: Emerging Technologies

By Paul Bjacek – Accenture Contributor: Kurt Eichhorn Mergers and acquisitions in the global chemicals industry have tumbled from their highs of the 2007­-2009 period, jolted by the Great Recession and despite the steady, albeit gradual, recovery in chemicals markets since then, M&A has not returned to those past levels. The reasons for the M&A slowdown are likely due … Read more

Creating More Value For China’s M&A

Figure 1 Examples of Chinese acquisitions in mature Western countries

by A.T. Kearney
Since China first opened to the world with the 1978 economic reforms, the country’s GDP has made unprecedented progress. It is a remarkable growth story. Although there is a big gap to close to catch up with the United States, China ranked second in the world in real GDP by 2013. By 2014, 100 Chinese companies were in the Fortune 500, up from 11 in 2000 and with petrochemical firm Sinopec holding the number-three spot. […] Read more

Creating More Value For China’s M&A

By Jian Sun, Sherri He, Joachim von Hoyningen-Huene, Andreas Graef, Thomas Luedi, Frankie Leung, Jürgen Rothenbuecher, Bastian Sauerberg – A.T. Kearney Since China first opened to the world with the 1978 economic reforms, the country’s GDP has made unprecedented progress. It is a remarkable growth story. Although there is a big gap to close to catch up with the United States, China ranked second in … Read more

Dealing With Uncertainty: Strategies For Overcoming Compliance Risk And Regulatory Challenges In Cross-Border M&A

Figure 1 Pharmerging Markets

by Baker & McKenzie
When you look at the numbers, there’s no question why global pharmaceutical companies have set their sights on emerging markets for future growth. From 2012 to 2017, global pharmaceutical sales are expected to rise 13% in the “pharmerging markets,” compared to 2% for the top mature markets, according to the IMS Institute for Healthcare Informatics. […] Read more

Are you sure you
want to log out?

In order to become a charterholder you need to complete one of the IMAA programs